Anti-clarin-1 AAV-delivered ribozyme induced apoptosis in the mouse cochlea

被引:11
作者
Aarnisalo, A. A. [1 ]
Pietola, L.
Joensuu, J.
Isosomppi, J.
Aarnisalo, P.
Dinculescu, A.
Lewin, A. S.
Flannery, J.
Hauswirth, W. W.
Sankila, E.-M.
Jero, J.
机构
[1] Univ Helsinki, Dept Otorhinolaryngol, Helsinki, Finland
[2] Biomed Helsinki Folkhalsan Inst Genet, Helsinki, Finland
[3] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland
[4] Univ Florida, Dept Ophthalmol & Mol Genet, Gainesville, FL USA
[5] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA
[6] Univ Helsinki, Dept Ophthalmol, Helsinki, Finland
关键词
clarin-1; Usher type 3; organ of corti; apoptosis;
D O I
10.1016/j.heares.2007.03.004
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Usher syndrome type 3 is caused by mutations in the USH3A gene, which encodes the protein clarin-1. Clarin-1 is a member of the tetraspanin superfamily (TM4SF) of transmembrane proteins, expressed in the organ of Corti and spiral ganglion cells of the mouse ear. We have examined whether the AAV-mediated anti-clarin ribozyme delivery causes apoptotic cell death in vivo in the organ of Corti. We used an AAV-2 vector delivered hammerhead ribozyme, AAV-CBA-Rz, which specifically recognizes and cleaves wild type mouse clarin-1 mRNA. Cochleae of CD-1 mice were injected either with 1 mu l of the AAV-CBA-Rz, or control AAV vectors containing the green fluorescent protein (GFP) marker gene (AAV-CBA-GFP). Additional controls were performed with saline only. At one-week and one-month post-injection, the animals were sacrificed and the cochleae were studied by histology and fluorescence imaging. Mice injected with AAV-CBA-GFP displayed GFP reporter expression of varying fluorescence intensity throughout the length of the cochlea in the outer and inner hair cells and stria vascularis, and to a lesser extent, in vestibular epithelial cells. GFP expression was not detectable in the spiral ganglion. The pro-apoptotic effect of AAV-CBA-delivered anti-clarin-1 ribozymes was evaluated by TUNEL-staining. We observed in the AAV-CBA-Rz, AAV-CBA-GFP and saline control groups apoptotic nuclei in the outer and inner hair cells and in the stria vascularis one week after the microinjection. The vestibular epithelium was also observed to contain apoptotic cells. No TUNEL-positive spiral ganglion neurons were detected. After one-month post-injection, the AAV-CBA-Rz-injected group had significantly more apoptotic outer and inner hair cells and cells of the stria vascularis than the AAV-CBA-GFP group. In this study, we demonstrate that AAV-CBA mediated clarin-1 ribozyme may induce apoptosis of the cochlear hair cells and cells of the stria vascularis. Surprisingly, we did not observe apoptosis in spiral ganglion cells, which should also be susceptible to clarin-1 mRNA cleavage. This result may be due to the injection technique, the promoter used, or tropism of the AAV serotype 2 viral vector. These results suggest the role of apoptosis in the progression of USH3A hearing loss warrants further evaluation. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 32 条
  • [1] USH3A transcripts encode clarin-1, a four- transmembrane-domain protein with a possible role in sensory synapses
    Adato, A
    Vreugde, S
    Joensuu, T
    Avidan, N
    Hamalainen, R
    Belenkiy, O
    Olender, T
    Bonne-Tamir, B
    Ben-Asher, E
    Espinos, C
    Millán, JM
    Lehesjoki, AE
    Flannery, JG
    Avraham, KB
    Pietrokovski, S
    Sankila, EM
    Beckmann, JS
    Lancet, D
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (06) : 339 - 350
  • [2] In vivo delivery of recombinant viruses to the fetal murine cochlea:: Transduction characteristics and long-term effects on auditory function
    Bedrosian, Jeffrey C.
    Gratton, Michael Anne
    Brigande, John V.
    Tang, Waixing
    Landau, Jessica
    Bennett, Jean
    [J]. MOLECULAR THERAPY, 2006, 14 (03) : 328 - 335
  • [3] Birikh KR, 1997, RNA, V3, P429
  • [4] Usher syndrome type III:: Revised genomic structure of the USH3 gene and identification of novel mutations
    Fields, RR
    Zhou, GM
    Huang, DL
    Davis, JR
    Möller, C
    Jacobson, SG
    Kimberling, WJ
    Sumegi, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (03) : 607 - 617
  • [5] Activation of heat-shock response by an adenovirus is essential for virus replication
    Glotzer, JB
    Saltik, M
    Chiocca, S
    Michou, AI
    Moseley, P
    Cotten, M
    [J]. NATURE, 2000, 407 (6801) : 207 - 211
  • [6] Ribozyme gene therapy for autosomal dominant retinal disease
    Hauswirth, WW
    LaVail, MM
    Flannery, JG
    Lewin, AS
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (02) : 147 - 153
  • [7] Specific tetraspanin functions
    Hemler, ME
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 155 (07) : 1103 - 1107
  • [8] Cochlear gene delivery through an intact round window membrane in mouse
    Jero, J
    Mhatre, AN
    Tseng, CJ
    Stern, RE
    Coling, DE
    Goldstein, JA
    Hong, K
    Zheng, WW
    Hoque, ATMS
    Lalwani, AK
    [J]. HUMAN GENE THERAPY, 2001, 12 (05) : 539 - 548
  • [9] A surgical approach appropriate for targeted cochlear gene therapy in the mouse
    Jero, J
    Tseng, CJ
    Mhatre, AN
    Lalwani, AK
    [J]. HEARING RESEARCH, 2001, 151 (1-2) : 106 - 114
  • [10] A sequence-ready map of the Usher syndrome type III critical region on chromosome 3q
    Joensuu, T
    Hämäläinen, R
    Lehesjoki, AE
    de la Chapelle, A
    Sankila, EM
    [J]. GENOMICS, 2000, 63 (03) : 409 - 416